Fremgangsmåte for fremstilling av et farmasöytisk preparat for forhindring av fibrinavsetning eller adhesjonsdannelse eller -nydannelse

A method and pharmaceutical composition for the prevention of fibrin deposition or adhesion formation by topical application of a composition to a site of potential fibrin deposition or adhesion formation comprising a sparingly soluble enzyme that is continuously released at that site for a period o...

Full description

Saved in:
Bibliographic Details
Main Authors MOHLER, MARJORIE A, NGUYEN, TUE H
Format Patent
LanguageNorwegian
Published 08.12.1997
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A method and pharmaceutical composition for the prevention of fibrin deposition or adhesion formation by topical application of a composition to a site of potential fibrin deposition or adhesion formation comprising a sparingly soluble enzyme that is continuously released at that site for a period of time of from about three days to two weeks which may include an inert adherence enhancing vehicle.
Bibliography:Application Number: NO19890005338